Cohort profile: genomic data for 26 622 individuals from the Canadian Longitudinal Study on Aging (CLSA). Issue 3 (10th March 2022)

• Record Type: Journal Article
• Authors: Forgetta, Vincenzo; Li, Rui; Darmond-Zwaig, Corinne; Belisle, Alexandre; Balion, Cynthia; Roshandel, Delnaz; Wolfson, Christina; Lettre, Guillaume; Pare, Guillaume; Paterson, Andrew D; Griffith, Lauren E; Verschoor, Chris; Lathrop, Mark; Kirkland, Susan; Raina, Parminder; Richards, J Brent; Ragoussis, Jiannis
• Is Part Of: BMJ open. Volume 12:Issue 3(2022)
• Publication Date: 2022-03-10
• Subjects: CLSA -- genome-wide genotyping -- aging -- HLA; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2021-059021
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Purpose: The Canadian Longitudinal Study on Aging (CLSA) Comprehensive cohort was established to provide unique opportunities to study the genetic and environmental contributions to human disease as well as ageing process. The aim of this report was to describe the genomic data included in CLSA. Participants: A total of 26 622 individuals from the CLSA Comprehensive cohort of men and women aged 45–85 recruited between 2010 and 2015 underwent genome-wide genotyping of DNA samples collected from blood. Comprehensive quality control metrics were measured for genetic markers and samples, respectively. The genotypes were imputed to the TOPMed reference panel. Sex chromosome abnormalities were identified by copy number profiling. Classical human leukocyte antigen gene haplotypes were imputed at two-field (four-digit). Findings to date: Of the 26 622 genotyped participants, 24 655 (92.6%) were identified as having European ancestry. These genomic data were linked to physical, lifestyle, medical, economic, environmental and psychosocial factors collected longitudinally in CLSA. The combined analysis, including CLSA genomic data, uncovered over 100 novel loci associated with key parameters to define glaucoma. The CLSA genomic dataset validated the contribution of a polygenic risk score to screen individuals with high fracture risk. It is also a valuable resource to directly identify common genetic variations associated with conditions related to complex traits. Taking advantage of the comprehensive interview and physical information collected in CLSA, this genomic dataset has been linked to psychosocial factors to investigate both the independent and interactive effects on cardiovascular disease. Future plans: The CLSA overall is ongoing. Follow-up data will continue to be collected from participants in the current genomic subcohort, including the DNA methylation and metabolomic data. Ongoing studies focus on elucidating the role of genetic factors in cognitive decline and cardiovascular diseases. This genomic data resource is available on request through the CLSA data access application process.